(Q51289170)

English

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.

scientific article published in January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study. (English)

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Shahin Akhondzadeh

10

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

object named as

Bahman Salehi

3

0 references

author name string

Amirhossein Modabbernia

1

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Farzin Rezaei

2

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Morteza Jafarinia

4

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Mandana Ashrafi

5

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Mina Tabrizi

6

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Seyed M R Hosseini

7

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

Ali Ghaleiha

9

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

publication date

1 January 2013

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

27

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

1

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

57-65

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

https://scigraph.springernature.com/pub.10.1007/s40263-012-0022-1

0 references

Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin shapes the neural circuitry of trust and trust adaptation in humans

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin increases gaze to the eye region of human faces

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin role in enhancing well-being: a literature review.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

The functional significance of social cognition in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Oxytocin and social affiliation in humans

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Brain oxytocin: a key regulator of emotional and social behaviours in both females and males

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Peripheral oxytocin is associated with reduced symptom severity in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Relationships among estrogen receptor, oxytocin and vasopressin gene expression and social interaction in male mice.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-012-0022-1

21 January 2018

Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neurobiology of trust.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variants in the oxytocin gene and risk for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxytocin: the great facilitator of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emotion recognition and oxytocin in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23233269

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40263-012-0022-1

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

1 reference

Europe PubMed Central

2 April 2018

http://europepmc.org/abstract/MED/23233269

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51289170&oldid=1566650763"